YUSIT1-B31 (Q54995804)

From Wikidata

Jump to navigation Jump to search

cell line

Language	Label	Description	Also known as
English	YUSIT1-B31	cell line

Statements

1 reference

Cellosaurus release 44

31 January 2023

cancer cell line

1 reference

Cellosaurus release 44

31 January 2023

parent cell line

1 reference

Cellosaurus release 44

31 January 2023

described by source

Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations

1 reference

Cellosaurus release 44

31 January 2023

established from medical condition

1 reference

Cellosaurus release 44

31 January 2023

derived from organism type

1 reference

Cellosaurus release 44

31 January 2023

Identifiers

1 reference

Cellosaurus release 44

31 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54995804&oldid=1861801794"